Previous Article | Next Article ![]()
Infection and Immunity, February 2000, p. 956-959, Vol. 68, No. 2
Department of Molecular Genetics,
Biochemistry, and Microbiology, University of Cincinnati,
Cincinnati, Ohio 45267-0524
Received 7 October 1999/Accepted 9 November 1999
Previous studies have reported that phagocytosed Bordetella
pertussis survives in human neutrophils. This issue has been
reexamined. Opsonized or unopsonized bacteria expressing green
fluorescent protein (GFP) were incubated with adherent human
neutrophils. Phagocytosis was quantified by fluorescence microscopy,
and the viability of phagocytosed bacteria was determined by colony
counts following treatment with polymyxin B to kill extracellular
bacteria. Only 1 to 2% of the phagocytosed bacteria remained viable.
Opsonization with heat-inactivated immune serum reduced the amount of
attachment and phagocytosis of the bacteria but did not alter survival
rates. In contrast to previous reports, these data suggest that
phagocytosed B. pertussis bacteria are killed by human neutrophils.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Phagocytosed Bordetella pertussis Fails
To Survive in Human Neutrophils

*
Corresponding author. Mailing address: Department of
Molecular Genetics, Biochemistry, and Microbiology, University of
Cincinnati, 231 Bethesda Ave., Cincinnati, OH 45267-0524. Phone: (513)
558-2820. Fax: (513) 558-8474. E-mail:
alison.weiss{at}uc.edu.
Present address: Biology Department, Drew University, Madison, NJ 07940.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|